IL-33 in clinical practice: Size matters? - 05/08/17
Doi : 10.1016/j.jaci.2017.03.042
Hideaki Morita, MD, PhD a, b, Susumu Nakae, PhD c, Hirohisa Saito, MD, PhD a, Kenji Matsumoto, MD, PhD a, ⁎ 
a Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan
b Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
c Laboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
∗Corresponding author: Kenji Matsumoto, MD, PhD, Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, Japan.Department of Allergy and Clinical ImmunologyNational Research Institute for Child Health and Development2-10-1 Okura, Setagaya-kuTokyoJapan
Key words : IL-33, alarmin, innate lymphoid cell, biological activity
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: H. Saito is employed by the National Center for Child Health & Development, Japan; has personally received payment for lectures from MSD (Merck Sharp and Dohme), Shiseido, GlaxoSmithKline, and Kyowa Hakko Kirin; and has personally received travel expenses from the World Allergy Organization, and his institution has received a grant from Ministry of Health, Labour & Welfare, Japan, for other works. K. Matsumoto is employed by National Research Institute for Child Health and Development; received payment for lectures from MSD (Merck Sharp and Dohme), Kyorin Pharmaceutical, AstraZeneca, Maruho, Teijin Pharma, and Chugai Pharmaceutical. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2017
Publié par Elsevier Masson SAS.
Vol 140 - N° 2
P. 381-383 - août 2017 Retour au numéro
Article précédent
- News Beyond Our Pages
- Marc E. Rothenberg, Jean Bousquet
- The future of allergy/immunology: Promising young investigators
- Cezmi A. Akdis, Zuhair K. Ballas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?